Researchers in the Life Sciences Interface Group in Tyndall are actively engaged with end users, industrial and academic partners leveraging innovative ICT technologies to provide solutions for applications in healthcare, security, agrifood and environment. New opportunities in these application sectors are being advanced through the convergence of ICT research in photonics, electronics, advanced materials and smart systems, with collaborators engaged from clinical, biotechnology, bioengineering and pharmaceutical research including industry partners (i.e. large multinational and SME companies) in many cases. Several research projects are currently ongoing in the Life Sciences Interface Group, based on research grants from EC (H2020) and national (e.g. Science Foundation Ireland and Enterprise Ireland) funding programmes.
The Life Sciences Interface Group in Tyndall is exploiting the extensive design, fabrication and characterisation tools available in Tyndall, to detect and characterize analytes, nucleic acids, proteins and cells. Integrated systems for analysis of various biomolecules have been developed which comprise of novel advanced sensors, electronic subsystems, software to interface with those sensors, and optimized surface chemistries to capture target molecules. The holistic approach within the Life Sciences Interface Group is typically based on identification of the user requirements specification of each application scenario, and proceeding through the development and integration of system building blocks. These include devices and modules for sample preparation, isolation, concentration / amplification, detection and characterisation of the target biomolecules. Integration of these modules into prototype systems with easy to use control systems has led to innovations in surface engineering, microfluidics, packaging, and signal processing.
Contact enquiry (at) tyndall (dot) ie for all Business Development enquiries